• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Referee.转移性肾细胞癌的部分肾切除术：评审意见
Eur Urol Open Sci. 2022 Aug 30;44:78-80. doi: 10.1016/j.euros.2022.08.007. eCollection 2022 Oct.
2
Partial nephrectomy in the setting of metastatic renal cell carcinoma.转移性肾细胞癌背景下的部分肾切除术。
J Urol. 2014 Jul;192(1):36-42. doi: 10.1016/j.juro.2014.01.086. Epub 2014 Feb 8.
3
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study.转移性肾细胞癌患者根据部分肾切除术与根治性肾切除术和年龄的差异：一项倾向评分匹配研究。
Surg Oncol. 2024 Apr;53:102047. doi: 10.1016/j.suronc.2024.102047. Epub 2024 Feb 13.
4
Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.部分肾切除术与根治性肾切除术治疗非转移性 T3a 期肾细胞癌：多机构比较分析。
Int J Urol. 2014 Apr;21(4):352-7. doi: 10.1111/iju.12283. Epub 2013 Sep 30.
5
Management of locally recurrent renal cell carcinoma after partial nephrectomy.肾部分切除术后局部复发性肾细胞癌的管理
J Urol. 1987 Sep;138(3):607-10. doi: 10.1016/s0022-5347(17)43273-3.
6
Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?部分肾切除术在转移性肾细胞癌患者中的作用如何？
Urol Oncol. 2013 Jan;31(1):36-41. doi: 10.1016/j.urolonc.2010.08.026. Epub 2011 Mar 10.
7
Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma.部分肾切除术作为减瘤手术在转移性肾细胞癌治疗中的作用
Minerva Urol Nefrol. 2015 Jun;67(2):149-56. Epub 2015 Feb 3.
8
Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.免疫治疗基础治疗后行细胞减积性肾切除术治疗转移性肾细胞癌：病例系列及文献复习。
Curr Oncol. 2021 May 20;28(3):1921-1926. doi: 10.3390/curroncol28030178.
9
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.帕唑帕尼治疗局限性肾细胞癌以优化保留肾实质的 II 期研究。
J Urol. 2015 Aug;194(2):297-303. doi: 10.1016/j.juro.2015.03.096. Epub 2015 Mar 23.
10
Complete remission of renal cell carcinoma with lung carcinomatous lymphangiosis after primary therapy with immune checkpoint inhibitors followed by partial nephrectomy for surgical consolidation.经免疫检查点抑制剂初始治疗后肾细胞癌合并肺癌性淋巴管炎完全缓解，随后行部分肾切除术进行手术巩固治疗。
IJU Case Rep. 2022 Mar 25;5(3):168-171. doi: 10.1002/iju5.12427. eCollection 2022 May.

引用本文的文献

1
Robot-assisted partial nephrectomy for renal cell carcinoma: A narrative review of different clinical scenarios.机器人辅助肾部分切除术治疗肾细胞癌：不同临床场景的叙述性综述
Asian J Urol. 2025 Apr;12(2):210-216. doi: 10.1016/j.ajur.2024.09.010. Epub 2025 Jan 25.
2
Effects of a Personalized Diet on Nutritional Status and Renal Function Outcome in Nephrectomized Patients with Renal Cancer.个性化饮食对肾癌肾切除术后患者营养状况和肾功能结局的影响。
Nutrients. 2024 May 3;16(9):1386. doi: 10.3390/nu16091386.

本文引用的文献

1
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con.转移性肾细胞癌的部分肾切除术：续
Eur Urol Open Sci. 2022 Aug 30;44:81-83. doi: 10.1016/j.euros.2022.07.011. eCollection 2022 Oct.
2
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro.转移性肾细胞癌的部分肾切除术：专家意见
Eur Urol Open Sci. 2022 Aug 30;44:92-93. doi: 10.1016/j.euros.2022.05.019. eCollection 2022 Oct.
3
Re: Comparison of immediate deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial.回复：接受舒尼替尼治疗的同步转移性肾细胞癌患者即刻与延迟减瘤性肾切除术的比较：SURTIME随机临床试验
Transl Cancer Res. 2019 Mar;8(Suppl 2):S208-S210. doi: 10.21037/tcr.2019.03.08.
4
The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma.细胞减灭性部分肾切除术对转移性肾细胞癌老年患者的影响。
Clin Interv Aging. 2020 Mar 20;15:431-439. doi: 10.2147/CIA.S243902. eCollection 2020.
5
Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study.局部肾肿瘤行部分肾切除术时切除技术对围手术期结局和手术切缘的影响：一项前瞻性多中心研究。
J Urol. 2020 Mar;203(3):496-504. doi: 10.1097/JU.0000000000000591. Epub 2019 Oct 14.
6
Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer.高血压与肾癌手术后心血管并发症。
Eur Urol Oncol. 2020 Apr;3(2):209-215. doi: 10.1016/j.euo.2019.02.006. Epub 2019 Mar 25.
7
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy.卡门娜真的应该改变我们对转移性肾细胞癌细胞减瘤性肾切除术的态度吗？一项系统评价和荟萃分析评估了靶向治疗时代的细胞减瘤性肾切除术。
Target Oncol. 2018 Dec;13(6):705-714. doi: 10.1007/s11523-018-0601-2.
8
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.对于转移性肾细胞癌，与根治性肾切除术相比，部分肾切除术似乎能带来生存益处。
Cancer Epidemiol. 2018 Oct;56:118-125. doi: 10.1016/j.canep.2018.08.006. Epub 2018 Aug 30.
9
Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.转移性肾细胞癌患者减瘤性部分肾切除术的使用趋势及其对总生存期的影响
Urol Oncol. 2018 Feb;36(2):78.e21-78.e28. doi: 10.1016/j.urolonc.2017.09.030. Epub 2017 Nov 8.
10
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较：系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Referee.

作者信息

Minervini Andrea, Grosso Antonio Andrea, Di Maida Fabrizio

机构信息

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.

出版信息

Eur Urol Open Sci. 2022 Aug 30;44:78-80. doi: 10.1016/j.euros.2022.08.007. eCollection 2022 Oct.

DOI:10.1016/j.euros.2022.08.007
PMID:36060858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9437793/
Abstract
摘要